ロード中...
Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms
BACKGROUND: New sequencing technologies have enabled the identification of mutations in Ten-eleven-translocation 2 (TET2), an enzyme that catalyzes the conversion of 5-methylcytosine into 5-hydroxymethylcytosine (5-hmC) in myeloid neoplasms. We have recently identified reduced TET2 mRNA expression i...
保存先:
| 出版年: | Diagn Pathol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4793581/ https://ncbi.nlm.nih.gov/pubmed/26984174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-016-0476-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|